机译:HSP90抑制剂(NVP-AUY922)增强了BCL-2抑制剂(ABT-737)在表达BCL-2的小细胞肺癌中的抗癌作用
Biomedical Science and Engineering Interdisciplinary Program Korea Advanced Institute of Science;
Department of Oncology University of Ulsan College of Medicine Asan Medical Center;
Biomedical Science and Engineering Interdisciplinary Program Korea Advanced Institute of Science;
Department of Oncology University of Ulsan College of Medicine Asan Medical Center;
Department of Oncology University of Ulsan College of Medicine Asan Medical Center;
Department of Oncology University of Ulsan College of Medicine Asan Medical Center;
Department of Oncology University of Ulsan College of Medicine Asan Medical Center;
Biomedical Science and Engineering Interdisciplinary Program Korea Advanced Institute of Science;
Department of Oncology University of Ulsan College of Medicine Asan Medical Center;
Department of Oncology University of Ulsan College of Medicine Asan Medical Center;
Small cell lung cancer; BCL-2 inhibitor; HSP90 inhibitor; Combination therapy;
机译:HSP90抑制剂(NVP-AUY922)增强了BCL-2抑制剂(ABT-737)在表达BCL-2的小细胞肺癌中的抗癌作用
机译:BBT-2的选择性抑制剂ABT-737在小细胞肺癌中的治疗效果。
机译:HSP90抑制剂通过增加Bax / Bcl-2比增强Celecoxib对HT-29结肠直肠癌细胞的抗增殖和凋亡效应
机译:Bcl-2过表达抑制II型细胞中的血迹诱导的细胞凋亡
机译:优先的雌激素受体β配体抑制耐富夫司特的乳腺癌细胞增殖并降低Bcl-2表达。
机译:Noxa的诱导将表达Mcl-1的人类结直肠癌细胞向小分子Bcl-2 / Bcl-xL抑制剂ABT-737敏感。
机译:NOXA的诱导使表达MCL-1的人结肠直肠癌细胞敏感到小分子BCL-2 / BCL-XL抑制剂,ABT-737